Medicare Decisions May Affect Cancer Treatment

Medicare now pays doctors less to give hormone injections to treat prostate cancer. The hormones stop testosterone from being made. This helps keep the cancer in check. After Medicare reduced these payments, fewer men got the shots. More men started getting surgery to stop testosterone instead. A study found that doctors gave fewer shots after Medicare cut payments in half. The study appears in the April 7 online version of the journal Cancer. The Associated Press wrote about the study the same day it was published online.